Blood clots form in response to signals from the lungs of cancer patients -- not from other organ sites, as previously thought -- according to a preclinical study. Clots are the second-leading cause ...
11h
CNET on MSNHow Your Blood Type Offers Clues Into Your Heart HealthYour blood type and its connection to your heart is more important than you think. Here's what it may mean for your health.
The study revealed the risk of developing venous thromboembolisms from various types of synthetic hormones, providing ...
Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots.
Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
I sat through almost every day of Letby's two trials at Manchester Crown Court - and subsequent appeals - and admit I was ...
Dignity Health Atrial fibrillation (AFib) is a common heart rhythm disorder that affects millions of people worldwide. By 2030, it is estimated that 12 million Americans will have ...
12h
healthshots on MSNCan you cure congenital heart defect? Expert answers 14 common questions about the birth defectCongenital heart defect is a problem that arises when the heart does not develop normally before birth. On Congenital Heart ...
4h
Hosted on MSNFrequent Anger Linked to Higher Heart Disease RiskOccasional anger is normal and generally has little effect on heart health, the researchers say. “If you’re a person who gets ...
Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results